Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adenosine-guided elimination of dormant conduction during pulmonary vein isolation for paroxysmal atrial fibrillation
2009-017314-76Phase 3Active
- Sponsor
- Montréal Heart Institute
- Start
- May 2010
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of adenosine in Atrial fibrillation (AFib) (2 arms), sponsored by Montréal Heart Institute. Started May 2010; status: active.
02
Drugs
adenosine
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on 2009-017314-76.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-017314-76.